| 1 | MoleculesMultidisciplinary Digital Publishing Institute | A1 | A2 | 203 | 192 (9%) |
| 2 | AntioxidantsMultidisciplinary Digital Publishing Institute | A1 | A1 | 165 | 34 (7%) |
| 3 | Carbohydrate PolymersElsevier BV | A1 | A1 | 153 | 23 (7%) |
| 4 | PharmaceuticsMultidisciplinary Digital Publishing Institute | A1 | A2 | 147 | 267 (18%) |
| 5 | Biomedicine & PharmacotherapyElsevier BV | A1 | A1 | 147 | 96 (15%) |
| 6 | Frontiers in PharmacologyFrontiers Media | A1 | A2 | 144 | 106 (11%) |
| 7 | Green ChemistryRoyal Society of Chemistry | A1 | A1 | 130 | 6 (7%) |
| 8 | Journal of NanobiotechnologyBioMed Central | A1 | A1 | 129 | 3 (10%) |
| 9 | Journal of Controlled ReleaseElsevier BV | A1 | A1 | 128 | 11 (16%) |
| 10 | Pharmacological ResearchElsevier BV | A1 | A1 | 110 | 12 (10%) |
| 11 | PharmaceuticalsMultidisciplinary Digital Publishing Institute | A1 | A2 | 110 | 135 (12%) |
| 12 | Journal of Medicinal ChemistryAmerican Chemical Society | A1 | A1 | 110 | 15 (19%) |
| 13 | PhytomedicineElsevier BV | A1 | A1 | 96 | 11 (9%) |
| 14 | Marine DrugsMultidisciplinary Digital Publishing Institute | A1 | A1 | 96 | 10 (7%) |
| 15 | Frontiers in ChemistryFrontiers Media | A1 | A2 | 92 | 21 (10%) |
| 16 | Journal of Molecular StructureElsevier BV | A1 | A2 | 90 | 41 (6%) |
| 17 | International Journal of PharmaceuticsElsevier BV | A1 | A1 | 89 | 122 (25%) |
| 18 | Journal of EthnopharmacologyElsevier BV | A1 | A1 | 87 | 139 (15%) |
| 19 | European Polymer JournalElsevier BV | A1 | A1 | 85 | 6 (9%) |
| 20 | Arabian Journal of ChemistryElsevier BV | A1 | A1 | 84 | 11 (10%) |
| 21 | Drug Discovery TodayElsevier BV | A1 | A1 | 81 | 4 (11%) |
| 22 | Phytotherapy ResearchWiley | A1 | A1 | 74 | 15 (13%) |
| 23 | Archives of ToxicologySpringer Science+Business Media | A1 | A1 | 67 | 9 (10%) |
| 24 | Annals of Translational MedicineAME Publishing Company Ressalva | A1 | A1 | 61 | 4 (7%) |
| 25 | Journal of Cosmetic DermatologyWiley | A1 | A3 | 52 | 19 (22%) |